Nogapendekin alfa inbakicept

ANKTIVA 400 microgram concentraat voor intravesicale suspensie

Concentraat voor intravesicale suspensieNetherlandsAuthorisedAuthorised 16 Feb 2026

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

AnktivaEuropean UnionAuthorised

Anktiva 400 Microgramos Concentrado Para Suspension IntravesicalSpain · 400 µg/dosis · concentrado para suspensión intravesical · Immunitybio Ireland LimitedSame brand
AnktivaEuropean Union · Immunitybio Ireland LimitedSame brand
AnktivaCroatiaSame brand
AnktivaItaly · Concentrato per sospensione endovescicale · Immunitybio Ireland LimitedSame brand
AnktivaUnited States · 400mcg/0.4 mL · solution · Altor Bioscience, LLC, An Indirect Wholly-Owned SuSame brand

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Nogapendekin alfa inbakicept

ANKTIVA 400 microgram concentraat voor intravesicale suspensie

Concentraat voor intravesicale suspensieNetherlandsAuthorisedAuthorised 16 Feb 2026

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

AnktivaEuropean UnionAuthorised

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Nogapendekin alfa inbakicept
Dosage form: Concentraat voor intravesicale suspensie
Route: Intravesicaal gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 16 Feb 2026
Registration: EU/1/25/2002
Marketing authorisation holder: ImmunityBio Ireland Limited
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/006622
EU number: EU/1/25/2002